Moreover, in breast cancer, dysregulated expression of MAP3K genes, such as MAP3K1 and MAP3K7, promotes tumor growth, invasion, and metastasis through activation of MAPK and NF-κB signaling pathways, mirroring their roles in GC [45, 46]. Here, NFKB1 is linked to breast cancer.